A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.

作者信息

Ochs Ashley

出版信息

Seton Hall Law Rev. 2009;39(2):559-603.

DOI:

PMID:19462540

Abstract

摘要

相似文献

[1]

A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.

Seton Hall Law Rev. 2009

[2]

FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.

Food Drug Law J. 2009

[3]

Access for the terminally ill to experimental medical innovations: a three-pronged threat.

Am J Bioeth. 2007-10

[4]

Access before approval--a right to take experimental drugs?

N Engl J Med. 2006-8-3

[5]

No way to save a life: allowing terminally ill patients access to drugs that have not completed clinical trials is a dangerous move.

New Sci. 2006

[6]

Expanded access to investigational drugs for treatment use. Final rule.

Fed Regist. 2009-8-13

[7]

The terminally ill, access to investigational drugs, and FDA rules.

Virtual Mentor. 2013-8-1

[8]

Charging for investigational drugs under an investigational new drug application. Final rule.

Fed Regist. 2009-8-13

[9]

The FDA's accelerated approval process: does the pharmaceutical industry have adequate incentives for self-regulation?

Am J Law Med. 1999

[10]

Constitutional law--substantive due process--en banc D.C. Circuit rejects fundamental right to experimental medications.--Abigail Alliance for Better Access to Developmental Drugs v. von Eschenbach, 495 F.3d 695 (D.C. Cir. 2007)(en banc), cert. denied, 128 S. Ct. 1069 (2008).

Harv Law Rev. 2008-4

引用本文的文献

[1]

Going "social" to access experimental and potentially life-saving treatment: an assessment of the policy and online patient advocacy environment for expanded access.

BMC Med. 2016-2-2

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献